FAM117A: A Potential Drug Target and Biomarker (G81558)

Target Name: FAM117A

NCBI ID: G81558

FAM117A

FAM117A: A Potential Drug Target and Biomarker

FAM117A, a gene encoding a protein known as FAM117A, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. FAM117A is a cytoplasmic protein that is expressed in most tissues and cells of the body. Its function in the cell is not well understood, but it is known to play a role in various cellular processes, including cell adhesion, migration, and invasion.

Potential Drug Target

FAM117A has been identified as a potential drug target due to its unique structure and its expression in various tissues. FAM117A is a transmembrane protein that contains a cytoplasmic region, a transmembrane region, and an intracellular region. Its cytoplasmic region contains a unique protein domain that is known as the N-terminal transmembrane domain. This domain is involved in the formation of the cytoplasmic tail, which is important for the protein's stability and localization to the cell surface.

FAM117A has been shown to interact with various drug targets, including tyrosine kinases, src tyrosine kinases, and FAK. These interactions suggest that FAM117A may be a drug target for diseases that are characterized by the over-expression or dysfunction of these protein targets.

Potential Biomarker

FAM117A has also been identified as a potential biomarker for various diseases. Its expression has been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that FAM117A may be a useful biomarker for these diseases.

FAM117A has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. Its expression has also been shown to be associated with the development and progression of various diseases, including cancer. This suggests that FAM117A may be a useful biomarker for cancer diagnosis and treatment.

Conclusion

In conclusion, FAM117A is a unique and highly expressed protein that has the potential to be a drug target and biomarker for various diseases. Its interaction with drug targets and its expression in various tissues make it an attractive candidate for further research. Further studies are needed to fully understand its function and its potential as a drug target and biomarker.

Protein Name: Family With Sequence Similarity 117 Member A

The "FAM117A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM117A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets